Rot, A. & von Andrian, U.H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22, 891–928 (2004).
Griffith, J.W., Sokol, C.L. & Luster, A.D. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu. Rev. Immunol. 32, 659–702 (2014).
Luther, S.A. & Cyster, J.G. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2, 102–107 (2001).
Krathwohl, M.D. & Kaiser, J.L. Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells 22, 109–118 (2004).
Ulvmar, M.H., Hub, E. & Rot, A. Atypical chemokine receptors. Exp. Cell Res. 317, 556–568 (2011).
Bachelerie, F. et al. New nomenclature for atypical chemokine receptors. Nat. Immunol. 15, 207–208 (2014).
Nibbs, R.J.B. & Graham, G.J. Immune regulation by atypical chemokine receptors. Nat. Rev. Immunol. 13, 815–829 (2013).
Bachelerie, F. et al. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol. Rev. 66, 1–79 (2013).
Pruenster, M. et al. The Duffy antigen receptor for chemokines transports chemokines and supports their pro-migratory activity. Nat. Immunol. 10, 101–108 (2009).
Ulvmar, M.H. et al. The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes. Nat. Immunol. 15, 623–630 (2014).
Lee, K.M. et al. The chemokine receptors ACKR2 and CCR2 reciprocally regulate lymphatic vessel density. EMBO J. 33, 2564–2580 (2014).
Cruz-Orengo, L. et al. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 208, 327–339 (2011).
Novitzky-Basso, I. & Rot, A. Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines. Front. Immunol. 3, 266 (2012).
Rot, A. Contribution of Duffy antigen to chemokine function. Cytokine Growth Factor Rev. 16, 687–694 (2005).
Mei, J. et al. CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection. Immunity 33, 106–117 (2010).
Schnabel, R.B. et al. Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein 1 and other inflammatory mediators. Blood 115, 5289–5299 (2010).
Reutershan, J., Harry, B., Chang, D., Bagby, G.J. & Ley, K. DARC on RBC limits lung injury by balancing compartmental distribution of CXC chemokines. Eur. J. Immunol. 39, 1597–1607 (2009).
Miller, L.H., Mason, S.J., Dvorak, J.A., McGinniss, M.H. & Rothman, I.K. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189, 561–563 (1975).
Horuk, R. et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261, 1182–1184 (1993).
Nedelec, Y. et al. Genetic ancestry and natural selection drive population differences in immune responses to pathogens. Cell 167, 657–669 (2016).
Quach, H. et al. Genetic adaptation and neandertal admixture shaped the immune system of human populations. Cell 167, 643–656 (2016).
Thobakgale, C.F. & Ndung'u, T. Neutrophil counts in persons of African origin. Curr. Opin. Hematol. 21, 50–57 (2014).
Reich, D. et al. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet. 5, e1000360 (2009).
Sanger, R., Race, R.R. & Jack, J. The Duffy blood groups of New York negroes: the phenotype Fy (a–b–). Br. J. Haematol. 1, 370–374 (1955).
Howes, R.E. et al. The global distribution of the Duffy blood group. Nat. Commun. 2, 266 (2011).
Tournamille, C., Colin, Y., Cartron, J.P. & Le Van Kim, C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10, 224–228 (1995).
Peiper, S.C. et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy-negative individuals who lack the erythrocyte receptor. J. Exp. Med. 181, 1311–1317 (1995).
Doss, J.F. et al. A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes. BMC Genomics 16, 952 (2015).
Thiriot, A. et al. Differential immunostaining of DARC (ACKR1) distinguishes venular from nonvenular endothelial cells in murine tissues. BMC Biol. 15, 45 (2017).
Dawson, T.C. et al. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 96, 1681–1684 (2000).
Itkin, T. et al. Distinct bone marrow blood vessels differentially regulate hematopoiesis. Nature 532, 323–328 (2016).
Morrison, S.J. & Scadden, D.T. The bone marrow niche for hematopoietic stem cells. Nature 505, 327–334 (2014).
Mendelson, A. & Frenette, P.S. Hematopoietic stem cell niche maintenance during homeostasis and regeneration. Nat. Med. 20, 833–846 (2014).
Fossati, G., Moots, R.J., Bucknall, R.C. & Edwards, S.W. Differential role of neutrophil Fcγ receptor IIIB (CD16) in phagocytosis, bacterial killing and responses to immune complexes. Arthritis Rheum. 46, 1351–1361 (2002).
Gao, H., Henderson, A., Flynn, D.C., Landreth, K.S. & Ericson, S.G. Effects of the protein tyrosine phosphatase CD45 on FcγRIIa signaling and neutrophil function. Exp. Hematol. 28, 1062–1070 (2000).
Minten, C. et al. DARC shuttles inflammatory chemokines across the blood–brain barrier during autoimmune central nervous system inflammation. Brain 137, 1454–1469 (2014).
Martin, C. et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 19, 583–593 (2003).
Busch, K. et al. Fundamental properties of unperturbed hematopoiesis from stem cells in vivo. Nature 518, 542–546 (2015).
Yu, V.W. et al. Epigenetic memory underlies cell-autonomous heterogeneous behavior of hematopoietic stem cells. Cell 167, 1310–1322 e1317 (2016).
Sun, J. et al. Clonal dynamics of native hematopoiesis. Nature 514, 322–327 (2014).
Pietras, E.M. et al. Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions. Cell Stem Cell 17, 35–46 (2015).
Bandyopadhyay, S. et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat. Med. 12, 933–938 (2006).
Hur, J. et al. CD82 (KAI1) maintains the dormancy of long-term hematopoietic stem cells through interaction with DARC-expressing macrophages. Cell Stem Cell 18, 508–521 (2016).
Youn, B.S., Mantel, C. & Broxmeyer, H.E. Chemokines, chemokine receptors and hematopoiesis. Immunol. Rev. 177, 150–174 (2000).
Sugiyama, T., Kohara, H., Noda, M. & Nagasawa, T. Maintenance of the hematopoietic stem cell pool by CXCL12–CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25, 977–988 (2006).
Gardner, L., Patterson, A.M., Ashton, B.A., Stone, M.A. & Middleton, J. The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. Biochem. Biophys. Res. Commun. 321, 306–312 (2004).
Ménard, D. et al. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc. Natl. Acad. Sci. USA 107, 5967–5971 (2010).
Miller, L.H., Mason, S.J., Clyde, D.F. & McGinniss, M.H. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295, 302–304 (1976).
Wright, D.E., Wagers, A.J., Gulati, A.P., Johnson, F.L. & Weissman, I.L. Physiological migration of hematopoietic stem and progenitor cells. Science 294, 1933–1936 (2001).
Seita, J. et al. Gene Expression Commons: an open platform for absolute gene expression profiling. PLoS One 7, e40321 (2012).
Faul, F., Erdfelder, E., Lang, A.-G. & Buchner, A. G*Power 3: a flexible statistical power analysis program for the social, behavioral and biomedical sciences. Behav. Res. Methods 39, 175–191 (2007).